格隆汇3月6日丨透云生物(01332.HK)公告,于2025年3月6日,卖方(公司的直接全资附属公司)与买方(一名独立第三方)已订立出售协议,据此,卖方已同意出售而买方已同意购买目标公司威道国际有限公司股份总数的30%,代价为人民币5,000,000元。目标公司为一间于香港注册成立的有限公司,主要从事提供产品包装上的二维码及解决方案以及广告展示服务。其为公司间接全资附属公司。尽管目标公司于2024...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.